William Ardrey

CustomVis Plc manufactured and sold laser optical equipment for use within the laser vision correction industry. The company's products included CustomVisTM and PULZAR Z1TM. It was founded in March 2001 and headquartered in Perth, Australia.

Part of Novartis AG, Novartis, Inc. is a company based in San Francisco.

QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada.

Avantogen Oncology, Inc. operates as a development stage company. It is engaged in the acquisition and development of novel compounds to treat patients with various types of cancer. The company was founded in 1986 and is headquartered in Pasadena, CA.

LaserSight, Inc. through its wholly-owned operating subsidiaries LaserSight Technologies, Inc. and LaserSight Patents, Inc engages in the development, manufacture & sale of ophthalmic lasers and related products primarily for use in laser vision correction, including laser in-situ keratomileusis & photorefractive keratectomy procedures. It also licenses patents related to refractive surgical procedures. The company was founded in 1987 and is headquartered in Winter Park, FL.

SciClone Pharmaceuticals LLC was engaged in the development of therapeutic treatment for oncology, infectious diseases, and cardiovascular disorders. It was also offering ZADAXIN for the treatment of hepatitis B, hepatitis C, certain cancers, and used as immune system enhancer, and DC Bead which is used for the novel treatment of liver cancer. The company was founded in 1990 and was headquartered in San Mateo, CA.